NasdaqCM - Delayed Quote USD
Nutriband Inc. (NTRB)
5.23
+0.17
+(3.36%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
Operating Cash Flow
-4,105.56
-3,527.51
-2,987.20
-2,809.22
-297.06
Investing Cash Flow
-141.18
-51.76
-79.30
-81.60
66.99
Financing Cash Flow
8,679.60
2,086.77
160.07
7,630.69
371.87
End Cash Position
5,698.19
492.94
1,985.44
4,891.87
151.99
Income Tax Paid Supplemental Data
2.04
--
--
--
--
Interest Paid Supplemental Data
0.61
7.35
4.27
18.60
11.56
Capital Expenditure
-141.18
-51.76
-79.30
-81.60
--
Issuance of Capital Stock
--
--
--
6,419.23
515.11
Issuance of Debt
300
2,106.53
--
--
194.87
Repayment of Debt
-20.40
-19.76
-17.80
-1,627.04
-356.41
Repurchase of Capital Stock
--
--
-119.01
-104.47
--
Free Cash Flow
-4,246.74
-3,579.27
-3,066.50
-2,890.82
-297.06
1/31/2021 - 10/1/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NTHI NeOnc Technologies Holdings, Inc. Common Stock
5.88
-2.00%
MRKR Marker Therapeutics, Inc.
1.1700
-1.68%
ATXI Avenue Therapeutics, Inc.
0.2580
-4.44%
VYNE VYNE Therapeutics Inc.
1.8400
-1.08%
GHRS GH Research PLC
9.50
+0.96%
CMMB Chemomab Therapeutics Ltd.
1.2000
+2.56%
SXTP 60 Degrees Pharmaceuticals, Inc.
3.0100
+12.73%
LXEO Lexeo Therapeutics, Inc.
3.3700
-1.46%
KROS Keros Therapeutics, Inc.
14.30
+2.95%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%